Display options
Cite
Eid CN, Halligan NG, Nicas TI, et al. Tripeptide LY301621 and its diastereomers as methicillin potentiators against methicillin resistant Staphylococcus aureus. J Antibiot (Tokyo). 1997;50(3):283-5
Eid, C. N., Halligan, N. G., Nicas, T. I., Mullen, D. L., Butler, T. F., Loncharich, R. J., Paschal, J. W., Schofield, C. J., Westwood, N. J., & Cheng, L. (1997). Tripeptide LY301621 and its diastereomers as methicillin potentiators against methicillin resistant Staphylococcus aureus. The Journal of antibiotics, 50(3), 283-5.
Eid, et al. "Tripeptide LY301621 and its diastereomers as methicillin potentiators against methicillin resistant Staphylococcus aureus." The Journal of antibiotics vol. 50,3 (1997): 283-5.
Eid CN, Halligan NG, Nicas TI, Mullen DL, Butler TF, Loncharich RJ, Paschal JW, Schofield CJ, Westwood NJ, Cheng L. Tripeptide LY301621 and its diastereomers as methicillin potentiators against methicillin resistant Staphylococcus aureus. J Antibiot (Tokyo). 1997 Mar;50(3):283-5. PMID: 9439706.
Copy Download .nbib Format: NLM
Share it on

J Antibiot (Tokyo). 1997 Mar;50(3):283-5.

Tripeptide LY301621 and its diastereomers as methicillin potentiators against methicillin resistant Staphylococcus aureus.

The Journal of antibiotics

Eid, Halligan, Nicas, Mullen, Butler, Loncharich, Paschal, Schofield, Westwood, Cheng

Affiliations

  1. Infectious Diseases Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA.

PMID: 9439706

[No abstract available.]

Publication Types